A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2
- PMID: 32682536
- PMCID: PMC7334949
- DOI: 10.1016/j.neurol.2020.06.001
A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2
Erratum in
-
Erratum to: "A first case of Mild Encephalitis with Reversible splenial lesions (MERS) as a presenting feature of SARS-CoV-2" [Rev. Neurol. 177 (1) (2020) 139-141].Rev Neurol (Paris). 2021 Oct;177(8):1045. doi: 10.1016/j.neurol.2021.09.002. Epub 2021 Sep 23. Rev Neurol (Paris). 2021. PMID: 34563380 Free PMC article. No abstract available.
Figures
Comment on
-
Reversible splenial lesion syndrome associated with encephalitis/encephalopathy presenting with great clinical heterogeneity.BMC Neurol. 2016 Apr 18;16:49. doi: 10.1186/s12883-016-0572-9. BMC Neurol. 2016. PMID: 27089920 Free PMC article.
References
-
- Tada H., Takanashi J., Barkovich A.J. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology. 2004;63(10):1854–1858. - PubMed
-
- Takanashi J., Imamura A., Hayakawa F., Terada H. Differences in the time course of splenial and white matter lesions in clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) J Neurol Sci. 2010;292(1–2):24–27. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous